Koch A, Buendgens L, Dückers H, Bruensing J, Matthes M, Kunze J, Herbers U, Lutz H H, Luedde T, Tischendorf J J W, Trautwein C, Tacke F
Medizinische Klinik III, Universitätsklinikum Aachen.
Z Gastroenterol. 2013 Jan;51(1):19-25. doi: 10.1055/s-0032-1330414. Epub 2013 Jan 11.
Due to portal hypertension and bleeding disorders, patients with liver cirrhosis are at increased risk for severe gastrointestinal bleedings (GIB), commonly requiring therapy at the intensive care unit (ICU). In order to identify epidemiological and prognostic factors for GIB in cirrhotic patients, we retrospectively analysed patients from our medical ICU from 1999 to 2010. Among 7376 critically ill patients, 650 (8.8 %) were diagnosed with liver cirrhosis. Hepatic cirrhosis was frequently found in ICU patients admitted due to severe GIB (23.2 % of 711 patients had cirrhosis). Moreover, patients with cirrhosis were at increased risk to develop severe GIB during intensive care treatment (40.9 % of 44 patients with GIB during ICU stay had cirrhosis). Besides the high rate of variceal bleedings (64.4 %) in cirrhotic patients, non-variceal haemorrhages were also common (28.5 %). We identified the MELD score and necessity of mechanical ventilation as independent risk factors for mortality in cirrhotic patients with severe GIB. Patients with liver cirrhosis and severe GIB had significantly impaired prognosis (case-related fatality rate of 26.1 % with cirrhosis vs. 6.8 % without cirrhosis), especially in cases of newly developed GIB during ICU therapy. Advanced therapeutic approaches and novel strategies are warranted to improve the critical prognosis of these high-risk patients.
由于门静脉高压和出血性疾病,肝硬化患者发生严重胃肠道出血(GIB)的风险增加,通常需要在重症监护病房(ICU)进行治疗。为了确定肝硬化患者GIB的流行病学和预后因素,我们回顾性分析了1999年至2010年我院医学ICU的患者。在7376例重症患者中,650例(8.8%)被诊断为肝硬化。在因严重GIB入院的ICU患者中经常发现肝硬化(711例患者中有23.2%患有肝硬化)。此外,肝硬化患者在重症监护治疗期间发生严重GIB的风险增加(在ICU住院期间发生GIB的44例患者中有40.9%患有肝硬化)。除了肝硬化患者静脉曲张出血率高(64.4%)外,非静脉曲张出血也很常见(28.5%)。我们确定终末期肝病模型(MELD)评分和机械通气的必要性是肝硬化合并严重GIB患者死亡的独立危险因素。肝硬化合并严重GIB患者的预后明显受损(肝硬化患者的病例死亡率为26.1%,无肝硬化患者为6.8%),尤其是在ICU治疗期间新发生GIB的病例中。需要先进的治疗方法和新策略来改善这些高危患者的危急预后。